Diagnostic Medical Radiation in Pediatric Patients With Inflammatory Bowel Disease
- 1 November 2011
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 53 (5) , 502-506
Abstract
Objectives: Certain diagnostic radiology procedures may expose patients with inflammatory bowel disease (IBD) to radiation and increase the risk for cancer. In the present study, we quantify the acute and cumulative effective dose of diagnostic radiation received by a cohort of pediatric patients with IBD.Patients and Methods: Patients with IBD were identified from the medical records of a pediatric tertiary care center. The number and type of radiology procedures for each patient were determined from medical record review. Cumulative effective radiation dose was calculated using radiation effective dose estimates.Results: One hundred five patients with IBD underwent radiation‐associated abdominopelvic diagnostic radiology procedures with an average cumulative radiation exposure dose of 15 (18) [mean (SD)] mSv. Forty‐two percent of the patients were exposed to acute radiation doses ≥10 mSv, and 6 patients (6%) were exposed to levels of cumulative radiation exposure ≥50 mSv, which has been associated with an increased risk of cancer development. Patients with Crohn disease, an increased number of hospital admissions, and a history of surgery were more likely to have been exposed to higher levels of cumulative radiation than their clinical counterparts.Conclusions: A majority of patients with IBD are exposed to radiation from typical diagnostic radiology procedures. Radiation‐sparing procedures should be strongly considered in certain pediatric patients with IBD to reduce their risk for cancer given an already present increased lifetime malignancy potential.Keywords
This publication has 23 references indexed in Scilit:
- Race and Inflammatory Bowel Disease in an Urban Healthcare SystemDigestive Diseases and Sciences, 2010
- Racial Disparities in Utilization of Specialist Care and Medications in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2010
- Risk of Radiation and Choice of ImagingDigestive Diseases, 2009
- Diagnostic Ionizing Radiation Exposure in a Population-Based Sample of Children With Inflammatory Bowel DiseasesAmerican Journal of Gastroenterology, 2009
- Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter RegistryClinical Gastroenterology and Hepatology, 2008
- Diagnostic Ionizing Radiation Exposure in a Population-Based Cohort of Patients with Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2008
- Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?Alimentary Pharmacology & Therapeutics, 2007
- Disease Presentation and Clinical Course in Black and White Children With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2007
- Infliximab Use and Hepatosplenic T Cell Lymphoma: Questions to Be Asked and Lessons LearnedJournal of Pediatric Gastroenterology and Nutrition, 2007
- Crohn's Disease: Presentation and Severity Compared Between Black Patients and White PatientsDiseases of the Colon & Rectum, 2005